Read More Pharma Industry News Novavax’s 2024-2025 COVID-19 Vaccine Receives EUA for Use in the U.S. Novavax, Inc. (Nasdaq: NVAX), a leading company in protein-based vaccines, has announced that its latest COVID-19 vaccine, the… byPallavi MadhirajuSeptember 1, 2024